SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
25-Jan-21 4:48 PM View: | Merus N.V. (MRUS) | 25-Jan-21 | Grant | 350,000 | $24.75 | $8,662,500.00 | 11% 3.2M to 3.55M | |
18-Jun-20 5:30 PM View: | Antigenics Inc. (AGEN) | 17-Jun-20 | Market Sale | 141,920 | $3.66 | $518,831.00 | (< 1%) 17.11M to 16.97M | (< 1%) |
18-Jun-20 5:30 PM View: | Antigenics Inc. (AGEN) | 16-Jun-20 | Market Sale | 72,080 | $3.66 | $264,007.00 | (< 1%) 17.19M to 17.11M | (< 1%) |
15-Jun-20 8:47 PM View: | Antigenics Inc. (AGEN) | 15-Jun-20 | Market Sale | 384,025 | $3.57 | $1,372,160.00 | (2%) 17.57M to 17.19M | (3%) |
15-Jun-20 8:47 PM View: | Antigenics Inc. (AGEN) | 12-Jun-20 | Market Sale | 9,100 | $3.58 | $32,556.20 | (< 1%) 17.58M to 17.57M | (3%) |
15-Jun-20 8:47 PM View: | Antigenics Inc. (AGEN) | 11-Jun-20 | Market Sale | 183,875 | $3.77 | $692,786.00 | (1%) 17.76M to 17.58M | 2% |
14-Feb-17 5:26 PM View: | Antigenics Inc. (AGEN) | 14-Feb-17 | Purchase | 10,000,000 | $6.00 | $60,000,000.00 | 129% 7.76M to 17.76M |